Nevertheless, further studies were validated not only because there were indications that a subset of patients with moderately severe COPD might have benefitted by oxygen supplementation but also ...

Please provide your email address to receive an email when new articles are posted on . Across several subgroups, more patients receiving ensifentrine vs. placebo were classified as Transitional ...

For patients with chronic obstructive pulmonary disease (COPD) with a history of exacerbations and a blood eosinophil count of at least 300 cells/µL, mepolizumab leads to a lower annualized rate of ...

Please provide your email address to receive an email when new articles are posted on . Patients with moderate or severe COPD experienced improvements with 3 mg of twice-daily ensifentrine. Study ...

"The evidence we have in persons with mild-to-moderate COPD, or who are minimally symptomatic, on reducing exacerbations and improving quality of life is still very limited." — Jennifer S. Lin, MD, ...

Certain glucose-lowering drugs were linked to fewer moderate or severe COPD exacerbations in adults with type 2 diabetes Study: Glucose-Lowering Medications and Risk of Chronic Obstructive Pulmonary ...

For patients with chronic obstructive pulmonary disease (COPD), budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol, according to ...

Emphysema is a lung disease that can develop after long-term tobacco use or exposure to secondhand smoke. It’s part of a group of lung diseases known as chronic obstructive pulmonary disease (COPD).

OAK BROOK, Ill. – Emphysema detected on baseline low-dose chest CT (LDCT) in the lung cancer screening cohort of more than 9,000 asymptomatic adults was associated with death from all causes, chronic ...